Page last updated: 2024-09-03

sch 23982 and bromocriptine

sch 23982 has been researched along with bromocriptine in 2 studies

Compound Research Comparison

Studies
(sch 23982)
Trials
(sch 23982)
Recent Studies (post-2010)
(sch 23982)
Studies
(bromocriptine)
Trials
(bromocriptine)
Recent Studies (post-2010) (bromocriptine)
87007,121727499

Protein Interaction Comparison

ProteinTaxonomysch 23982 (IC50)bromocriptine (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.532
Beta-1 adrenergic receptorHomo sapiens (human)2.4
Cytochrome P450 3A4Homo sapiens (human)2.4996
Alpha-2A adrenergic receptorHomo sapiens (human)0.015
D(2) dopamine receptorHomo sapiens (human)0.0016
Androgen receptorRattus norvegicus (Norway rat)2.281
Alpha-2B adrenergic receptorHomo sapiens (human)0.035
Alpha-2C adrenergic receptorHomo sapiens (human)0.52
DRattus norvegicus (Norway rat)0.0279
D(3) dopamine receptorRattus norvegicus (Norway rat)0.0279
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0056
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.514
D(1A) dopamine receptorHomo sapiens (human)2.889
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.514
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.514
Alpha-1D adrenergic receptorHomo sapiens (human)0.03
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.0279
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.036
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.532
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)0.0056
D(4) dopamine receptorRattus norvegicus (Norway rat)0.0279
D(3) dopamine receptorHomo sapiens (human)0.0006
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0083
5-hydroxytryptamine receptor 6Homo sapiens (human)0.022
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0279

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, EF; Fahlbusch, R; Nomikos, P; Reif, M; Schrell, UM1
Denis, P; Elena, PP; Lapalus, P; Nordmann, JP; Saraux, H1

Other Studies

2 other study(ies) available for sch 23982 and bromocriptine

ArticleYear
Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 71, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apomorphine; Benzazepines; Binding, Competitive; Bromocriptine; Butaclamol; Cell Division; Dopamine; Dopamine Agents; Humans; Meningioma; Receptors, Dopamine; Receptors, Dopamine D1; Tumor Cells, Cultured

1990
Autoradiographic localization of D1 and D2 dopamine binding sites in the human retina.
    Neuroscience letters, 1990, Aug-14, Volume: 116, Issue:1-2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aged; Aged, 80 and over; Autoradiography; Benzazepines; Bromocriptine; Domperidone; Dopamine Antagonists; Humans; Iodine Radioisotopes; Middle Aged; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Retina; Sulpiride

1990